News & Updates

I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font.

Jun 18, 2021

Design, construction and testing of a low-cost automated 68Gallium-labeling synthesis unit

Am J Nucl Med Mol Imaging. 2016; 6(3): 176–184. The interest in 68Gallium labeled PET probes continues to increase around the world....

Jun 18, 2021

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without MoCo

European Journal of Nuclear Medicine and Molecular Imaging. 2018 Nov;45(12):2147-2154. Purpose: To compare the clinical performance of...

Jun 18, 2021

18 F-Fluciclovine PET in Men With BCR PCa after Prostatectomy and planning for Salvage Radiation

Pract Radiat Oncol. Sep-Oct 2020;10(5):354-362 Purpose: Conventional imaging rarely localizes the site(s) of prostate cancer recurrence...

Jun 18, 2021

18 F-FES PET/CT Measurement of ER Suppression during a Phase I Trial of GDC-0810

Clin Cancer Res; 23(12); 3053-60. Purpose: Evaluate 18F-fluoroestradiol (FES) PET/CT as a biomarker of estrogen receptor (ER) occupancy...

Jun 18, 2021

C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease

Int J Radiat Oncol Biol Phys. 2018 Nov 15; 102(4): 1024–1028. Purpose: Response criteria of glioblastoma after chemoradiation do not...

Jun 18, 2021

Clinical impact of PET/MR in treated colorectal cancer patients

European Journal of Nuclear Medicine and Molecular Imaging. 2019 Oct;46(11):2260-2269. Purpose: The primary aim of the present study was...

Jun 18, 2021

Management implications of FDG PET/MR in untreated intrahepatic cholangiocarcinoma

European Journal of Nuclear Medicine and Molecular Imaging. 2020 Jul;47(8):1871-1884. Purpose: Intrahepatic cholangiocarcinoma (ICC) is...

Jun 18, 2021

A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases

Oncologist. 2020 Aug; 25(8): 652–660. Background We assessed the antitumor activity of cabozantinib, a potent multireceptor oral tyrosine...

Jun 18, 2021

Improving staging of rectal cancer in the pelvis: the role of PET/MRI

European Journal of Nuclear Medicine and Molecular Imaging. 2021 Apr;48(4):1235-1245. Purpose The role of positron emission...

Jun 18, 2021

PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analys

European Journal of Nuclear Medicine and Molecular Imaging. volume 48, pages 1976–1986 (2021) Purpose To evaluate PET/MR lung nodule...

Jun 18, 2021

Evaluation of the Diagnostic Performance of PET/MR for the Diagnosis of Liver Metastases

Invest Radiol. 2021 Mar 25. Objective: The aim of this study was to compare the performance of positron emission tomography...

Jun 16, 2021

The Impact of PET with 18F-Fluciclovine on the Treatment of BCR of PCa: Results from the LOCATE Tria

J Urol. 2019 Feb; 201(2): 322–331. Purpose: The prospective, multicenter LOCATE (F Fluciclovine [FACBC] PET/CT in Patients with Rising...

Jun 16, 2021

Multitargeted TKI produces discordant changes between 99mTc-MDP bone scans and other biomarkers

J Nucl Med. 2012 Nov; 53(11): 1670–1675. Purpose: One of the central unanswered questions in prostate cancer research is the significance...

Jun 16, 2021

Prospective trial with optical molecular imaging for percutaneous interventions in hepatic lesions

Radiology. 2015 Mar;274(3):917-26. Purpose: To demonstrate the clinical translation of optical molecular imaging (OMI) for the...

Jun 16, 2021

Pilot Clinical Trial of Indocyanine Green Fluorescence-Augmented Colonoscopy in High Risk Patients

Gastroenterol Res Pract. 2016; 2016: 6184842. White light colonoscopy is the current gold standard for early detection and treatment of...

Jun 15, 2021

Performance of fluciclovine PET/MR in the evaluation of osseous metastases from CRPC

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):105-114. Purpose: 18F-Fluciclovine is indicated for evaluation of suspected prostate cancer...

Jun 15, 2021

Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma

Abdom Radiol (NY). 2021 Mar 27. Purpose: Radiation therapy (RT) is an effective treatment for unresectable cholangiocarcinoma (CC)....

Jun 15, 2021

Baseline TLG measured with FDG PET/CT as a predictor of PFS in DLBCL

Am J Nucl Med Mol Imaging. 2013; 3(3): 272–281. This pilot study investigates the value of baseline total lesion glycolysis (TLG) in...

Jun 15, 2021

A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68 Ga-DOTATOC

Am J Nucl Med Mol Imaging. 2017; 7(2): 53–62. This prospective pilot study provides a dynamic whole body PET/MR image database, clinical...